syngo.CT CaScoring vs iCAC Device
AI Verdict
Choose syngo.CT CaScoring if…
Choose syngo.CT CaScoring if your institution performs dedicated cardiac CT scans and requires precise, detailed quantification and visualization of coronary calcifications for comprehensive cardiovascular risk assessment and documentation. This tool is particularly well-suited for integration within a Siemens imaging ecosystem, offering advanced features like plaque burden assessment per artery and comparison to reference groups.
View syngo.CT CaScoring →Choose iCAC Device if…
Choose iCAC Device if your primary objective is opportunistic screening for coronary artery calcium from routine, non-contrast, non-gated chest CT scans that were not initially ordered for cardiac evaluation. This cloud-based SaMD solution is ideal for identifying early cardiovascular disease risk by leveraging existing imaging data, providing adjunctive information to radiologists and integrating seamlessly with PACS or EHRs.
View iCAC Device →When choosing between syngo.CT CaScoring and iCAC Device, physicians should consider their existing infrastructure and primary use case. Syngo.CT CaScoring, integrated with Siemens CT systems, excels at detailed, dedicated coronary calcium scoring from cardiac-gated CT scans. It offers comprehensive quantification, including Agatston score, volume, and calcium mass, along with comparisons to reference groups and ‘Coronary Age’ calculations. This tool is best suited for practices already utilizing Siemens CT scanners and performing dedicated cardiac CTs for cardiovascular risk assessment.
The key practical difference lies in their deployment and data input. Syngo.CT CaScoring operates as a post-processing application on the syngo.via platform, requiring Siemens CT scans. In contrast, Bunkerhill Health’s iCAC Device is a cloud-based Software as a Medical Device (SaMD) that can analyze coronary artery calcium from routine, non-contrast, non-gated chest CT scans, integrating with PACS or DICOM routers. This makes iCAC ideal for opportunistic screening, allowing for the detection and quantification of coronary artery calcium from existing or incidental chest CTs, without the need for a dedicated cardiac scan.
Therefore, a physician with a Siemens CT ecosystem focused on detailed cardiac risk assessment would likely prefer syngo.CT CaScoring. Conversely, a practice seeking to leverage existing non-contrast chest CT data for broader, opportunistic cardiovascular disease detection and early intervention, regardless of CT scanner vendor, would find the iCAC Device more suitable due to its flexible deployment and ability to analyze routine scans.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | syngo.CT CaScoring | iCAC Device |
|---|---|---|
| Pricing | Contact for pricing | Contact for pricing |
| Deployment | Integrated with Siemens CT scanner systems; operates as a post-processing application on the multi-user syngo.via client/server platform. | Software as a Medical Device (SaMD), integrates with PACS or DICOM router. Cloud-based (via Carebricks platform). |
| FDA Status | 1 AI-estimated | 1 AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
iCAC DeviceTool B (iCAC Device) offers superior usability due to its flexible cloud-based Software as a Medical Device (SaMD) deployment, integrating with PACS or DICOM routers. Crucially, it can analyze routine, non-contrast, non-gated chest CT scans, enabling opportunistic identification of coronary artery calcium without requiring dedicated scans or disrupting existing workflows. Tool A, while well-integrated within the Siemens syngo.via ecosystem, is more confined to that specific platform and dedicated cardiac CT acquisitions.
Clinical Value
syngo.CT CaScoringWhile both tools provide robust Agatston scoring, Tool A (syngo.CT CaScoring) offers a more comprehensive clinical assessment for dedicated CAC scoring. It quantifies not only the Agatston score but also volume, calcium mass, and plaque burden per individual coronary artery, along with comparison to multiple healthy reference groups (e.g., MESA study) and calculation of 'Coronary Age'. Tool B's strength lies in opportunistic detection, but Tool A provides more granular data for in-depth risk stratification.
Pricing & Value
syngo.CT CaScoringTool A (syngo.CT CaScoring) provides more transparency regarding its pricing model, specifying a one-time license purchase and even offering a historical list price. In contrast, Tool B (iCAC Device) provides no public pricing details, requiring direct vendor contact, which makes it difficult for potential buyers to assess its value proposition upfront.
Enterprise Readiness
syngo.CT CaScoringTool A (syngo.CT CaScoring) is developed by Siemens Medical Solutions USA, a globally recognized and established leader in healthcare technology. This affiliation implies a robust infrastructure, proven enterprise-level support, and a strong track record of compliance and security, offering greater assurance for large-scale deployments compared to a newer company like Bunkerhill Health (Tool B).
Innovation
iCAC DeviceTool B (iCAC Device) demonstrates greater innovation through its ability to detect and quantify coronary artery calcium from routine, non-contrast, non-gated chest CT scans. This 'opportunistic identification' leverages existing imaging data to proactively identify cardiovascular risk in a broader patient population, representing a significant shift in early disease detection and population health screening. While Tool A offers innovative features like 'Coronary Age,' Tool B's approach is more disruptive to traditional screening paradigms.
Support & Docs
syngo.CT CaScoringAs a product from Siemens Healthineers, a major global medical technology company, syngo.CT CaScoring (Tool A) benefits from an extensive and well-established support network, comprehensive documentation (including Instructions for Use), and readily available training resources. Specific support and documentation details for Bunkerhill Health's iCAC Device (Tool B) are not publicly available, making Tool A the more reliable choice in this dimension.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | syngo.CT CaScoring | iCAC Device |
|---|---|---|
| Name | syngo.CT CaScoring | iCAC Device |
| Company | Siemens Medical Solutions USA | Bunkerhill Health |
| Description | AI-powered image analysis software for quick quantification and accurate visualization of calcified coronary lesions from CT scans, aiding in cardiovascular risk assessment and documentation. | FDA-cleared AI algorithm that detects and quantifies coronary artery calcium from routine, non-contrast, non-gated chest CT scans, aiding in early cardiovascular disease detection. |
| Key Features (Examples) | Quick quantification and accurate visualization of calcified coronary lesions; Calculation of Agatston Score, volume, and calcium mass; Comparison of patient score to healthy reference groups (e.g., MESA study). | Estimates presence and quantity of coronary artery calcium (CAC); Analyzes routine, non-contrast, non-gated chest CT scans; Delivers exact and four-category quantitative estimates of CAC burden in Agatston units. |
Videos
Demos, reviews, and walkthroughs featuring syngo.CT CaScoring and iCAC Device.